Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06761599

Frequency of Pulmonary Toxicity in Patients Treated for Hodgkin Lymphoma

Sponsor: Superior University

View on ClinicalTrials.gov

Summary

Pulmonary toxicity during Hodgkin lymphoma treatment is significant for a variety of reasons, ranging from clinical care to therapeutic innovation and patient outcomes.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

214

Start Date

2024-02-18

Completion Date

2025-03-01

Last Updated

2025-01-07

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

group 1

To determine treatment-induced pulmonary toxicity prevalence and risk factors in Hodgkin lymphoma patients during chemotherapy or radiation therapy.

Locations (1)

Shaukat Khanum Memorial Cancer Hospital and Research Centre, 5-B, Sector A2, Phase 5, Hayatabad

Peshawar, Khyber Pakhtunkhwa, Pakistan